Výsledky vyhledávání

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

Autor: R. Lefur, J. Ton Van, Y. Koskas, Christian Domenge, M Bolla, A Laplanche, J.M Badet

Publikováno v: European Journal of Cancer. 30:767-772

Patients who are cured from head and neck carcinomas remain at high risk for developing a second primary in the head and neck area. It is now clear that retinoids exert a prophylactic action on the development of epithelial cancers when tested on lab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6236b39d901abf92e386a4987b0dad8
https://doi.org/10.1016/0959-8049(94)90290-9

Zobrazit plný text záznamu

Prevention of second primary tumours with a second generation retinoid in squamous cell carcinoma of oral cavity and oropharynx: Long term follow-up

Autor: R. Lefur, Jean-Louis Lefebvre, Agnès Laplanche, J. Ton Van, Christian Domenge, Michel Bolla, Bernard Luboinski

Publikováno v: European Journal of Cancer. 32:375-376

Retinoids exert a prophylactic action on the development of epithelial cancers when tested on human premalignant lesions, and are now used in the chemoprevention of epithelial cancers, in randomized trials. We prospectively studied 316 patients who d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68a39c541cbe2148659df6866d8d421b
https://doi.org/10.1016/0959-8049(95)00521-8

Zobrazit plný text záznamu

321 Hyperfractionated (HF) and accelerated (AF) radiotherapy (RT) in head and neck cancers: Facts from trials, impact on standard practice

Autor: D. Lopez Torrecilla, R. Lefur, M. Pierart, D. van den Weijngaert, T. N'Guyen, W. Van den Bogaert, P. Bontemps, M. Bolla, A.C. Begg, A. Lusinchi, M. van Glabbeke, J. Bernier, B. Jancar, D. Stuschke, Horiot Jc

Publikováno v: European Journal of Cancer. 31:S69

From 1978 to 1995, 2165 patients (pts) were entered in trials of HF or AF RT. Two randomized trials in head and neck cancers accrued 867 pts: Protocol 22791 (356 pts, 1980–87) compared CF (70 Gy/35–40 fr/7–8 wks) to HF (80.5 Gy/70 fr/7 wks) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::494bc9c6503c37c381d82e56a195819e
https://doi.org/10.1016/0959-8049(95)95577-s

Zobrazit plný text záznamu

Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French society of pediatric oncology (SFOP) and hôpital Saint-Louis, Paris

Autor: O. Le Floch, P.H. Thierry, Jacques R. Vilcoq, L. Dutou, Jean-Louis Habrand, Odile Oberlin, C. Dionet, Pierre Bey, R. Lefur, M. Madelain, Danièle Sarrazin

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 15:341-346

To minimize the drawbacks of treatment we had shown in a previous study that it was possible after chemotherapy to limit the radiation fields to the involved areas only. Pursuing our policy of deescalation, we started in January 1982 a study in 29 Fr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa01f7dcd14207235aaecc34600f8d0
https://doi.org/10.1016/s0360-3016(98)90013-x

Zobrazit plný text záznamu

Combined radiotherapy-chemotherapy for early stages non-Hodgkin'slymphoma: The 1975–1980 EORTC controlled lymphoma trial

Autor: Jean-Marc Cosset, M. M. Qasim, Riet Somers, J. S. Abbatucci, R. Lefur, M. Hayat, M. van Glabbeke, M. Tubiana, W. Sizoo, J. M. V. Burgers, Patrice Carde

Publikováno v: Radiotherapy and Oncology. 2:301-312

Summary Patients with stage I and II non-Hodgkin's lymphoma (NHL) are considered to have a relatively good prognosis. For this reason, they are seldom referred to specialized centers and the accrual of such patients in controlled studies is limited.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601417ac10a37e765a311974105ef2ca
https://doi.org/10.1016/s0167-8140(84)80072-9

Zobrazit plný text záznamu

TELECOBALT THERAPY FOR CARCINOMA OF LARYNGOPHARYNX

Autor: G. Juillard, C. M. Lalanne, R. Lefur, Y. Cachin

Publikováno v: American Journal of Roentgenology. 111:78-84

1. In small lesions, T1 and T2, of the laryngopharynx, telecobalt therapy gives as good results as the combination of surgery anti pre- and postoperative telecobalt therapy.2. On the other hand, in larger lesions, T3 and T4, surgery supplemented by r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7371a4b39a8a0da28807fe3048c83139
https://doi.org/10.2214/ajr.111.1.78

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání